Bioperfectus Technologies
Founded Year
2010Stage
IPO | IPOTotal Raised
$5.01MDate of IPO
12/5/2019Market Cap
0.47BStock Price
7.97About Bioperfectus Technologies
Bioperfectus Technologies (688399.SH) is a developer of nucleic acid and protein detection products. The company has multiple fluorescent quantitative PCR, biochips, enzyme chemistry and other biological technology platforms.
Loading...
Loading...
Bioperfectus Technologies Frequently Asked Questions (FAQ)
When was Bioperfectus Technologies founded?
Bioperfectus Technologies was founded in 2010.
Where is Bioperfectus Technologies's headquarters?
Bioperfectus Technologies's headquarters is located at The third-floor factory building and the third and fourth-floor research and development area, Taizhou.
What is Bioperfectus Technologies's latest funding round?
Bioperfectus Technologies's latest funding round is IPO.
How much did Bioperfectus Technologies raise?
Bioperfectus Technologies raised a total of $5.01M.
Who are the investors of Bioperfectus Technologies?
Investors of Bioperfectus Technologies include Huatai Zijin Investment and Nanjing Daoxing.
Loading...
Loading...